Case Studies
Our assays in action: commercial launches, peer-reviewed clinical research and active collaborations in microbiome science.
REM in numbers
ce-ivd
regulatory certification
Commercial Product Launches
YoniSolutions — Vaginal Microbiome Testing Kit
Swiss women’s health diagnostics company
CE-IVD certified | Available in Switzerland & Europe
Challenge
Existing tests provided either limited information or data overload (metagenomics) without clear interpretation
Solution
Targeted assay identifying protective versus transitional Lactobacillus species and quantifying Gardnerella vaginalis and Candida species
Impact
A CE-IVD marked test launched in Switzerland and Europe, where healthcare providers use the results to guide personalized recommendations
Key Outcome
Women and providers receive interpretable results showing which Lactobacillus species are present and their relative abundance, informing treatment decisions
Upcoming Launch: Elements
Launching Soon | Gut Health Profiling
Challenge
Functionally distinct Bifidobacterium subspecies require precise identification for accurate gut health assessment.
Solution
Subspecies-level assay identifying functionally distinct Bifidobacterium strains, including B. longum subspecies differentiation and commercial probiotic strain detection
Impact
REM’s first commercial gut health test, offering subspecies-level Bifidobacterium analysis to guide evidence-based probiotic and dietary recommendations.
Key Outcome
Distinguishes Bifidobacterium subspecies with different biological functions, providing the resolution needed for precise probiotic strain selection and dietary intervention strategies.
Case Studies (Past Projects)
Research partnerships demonstrating how our targeted assays contribute to identifying biological markers that support clinical and agricultural findings.
Nutrishield (Horizon2020)
Obesity Risk in Young Populations: Associations with Specific Bifidobacterium Subspecies
Project
Horizon 2020 (2018-2023) | Evidence-based personalised nutrition for the young | Clinical validation studies
REM’s role
Subspecies-resolved Bifidobacterium profiling across clinical cohorts
KEY FINDINGS
B. longum subsp. infantis and B. bifidum showed obesity associations not detectable at genus or species level. Subspecies-level data correlated with macronutrient intake and urinary metabolites.
Code:Re-farm (Horizon 2020)
Linking Milk Quality to Farming Practices Through Microbiome Community Profiling
Project
Horizon 2020 (2021-2025) | Consumer-driven demands to reframe farming systems | ~300 samples across 4 pilot farms
REM’s role
Milk microbiome assay development and microbial profiling across diverse production systems
KEY FINDINGS
Identified distinct microbial signatures specific to individual farms. Microbial community composition correlated with milk protein content and production system type.
Active Research Partnerships
Current Horizon Europe collaborations in agricultural microbiome research and nutrition science
Partnership Opportunities
REM partners with organizations across the microbiome, diagnostics, agriculture, and food sectors on targeted assay development and collaborative research. Application areas range from clinical pathogen detection and probiotic validation to food authentication and production monitoring.